Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX
Titel:
Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX
Auteur:
Dimopoulos, Meletios Belch, Andrew R. White, Darrell J. Benboubker, Lofti Cook, Gordon Leiba, Merav Morton, James Ho, P. Joy Kim, Kihyun Takezako, Naoki San-Miguel, Jesus Moreau, Philippe Kaufman, Jonathan L. Sutherland, Heather Lalancette, Marc Magen, Hila Iida, Shinsuke Kim, Jin Seok Prince, H. Miles Cochrane, Tara Oriol, Albert Chari, Ajai O'Rourke, Lisa Wu, Kaida Casneuf, Tineke Chiu, Christopher Soong, David Qin, Xiang Sasser, Kate Khokhar, Nushmia